LPL Financial’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.87K Buy
589
+88
+18% +$1.63K ﹤0.01% 6180
2026
Q1
$8.15K Buy
501
+78
+18% +$1.72K ﹤0.01% 5934
2025
Q4
$10K Buy
+423
New +$12.5K ﹤0.01% 5849
2023
Q1
Sell
-173
Closed -$25.7K 4587
2022
Q4
$25.7K Sell
173
-114
-40% -$20.7K ﹤0.01% 4341
2022
Q3
$46K Sell
287
-38
-12% -$7.35K ﹤0.01% 4243
2022
Q2
$60K Sell
325
-353
-52% -$64.6K ﹤0.01% 4214
2022
Q1
$108K Sell
678
-35
-5% -$6.05K ﹤0.01% 3962
2021
Q4
$153K Buy
713
+119
+20% +$33.7K ﹤0.01% 4052
2021
Q3
$192K Buy
594
+194
+49% +$68.3K ﹤0.01% 4001
2021
Q2
$177K Buy
400
+253
+172% +$126K ﹤0.01% 3940
2021
Q1
$83K Buy
+147
New +$106K ﹤0.01% 3950
2015
Q2
Sell
-122
Closed -$352K 2944
2015
Q1
$352K Buy
+122
New +$338K ﹤0.01% 2116
2014
Q3
Sell
-219
Closed -$756K 2782
2014
Q2
$756K Buy
+219
New +$779K ﹤0.01% 1517
2014
Q1
Sell
-74
Closed -$280K 2720
2013
Q4
$280K Sell
74
-21
-22% -$75.6K ﹤0.01% 2173
2013
Q3
$322K Sell
95
-7
-7% -$20.5K ﹤0.01% 1962
2013
Q2
$259K Buy
+102
New +$254K ﹤0.01% 2011

Other funds holding TRIB

LPL Financial's TRIB Position: Q2 2026 in Review

LPL Financial increased its Trinity Biotech (TRIB) stake by 18% in Q2 2026, buying an estimated $1.63K and bringing the position to 589 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #6180.

LPL Financial first reported a position in TRIB in Q2 2013 and has held it in 16 quarters since. The position peaked at $756K in Q2 2014. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • LPL Financial held 589 shares of Trinity Biotech worth $6.87K as of Q2 2026.
  • LPL Financial bought 88 Trinity Biotech shares in Q2 2026, an estimated $1.63K.
  • Trinity Biotech made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6180 holding.
  • LPL Financial first reported a position in Trinity Biotech in Q2 2013 and has held it in 16 quarters since.
  • LPL Financial's Trinity Biotech position peaked at $756K in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.